Yes. Thank you, Chair.
With regard to the powers in the act, there are fines and injunctions available if companies refuse to register their clinical trials, and of course the regulator can always refuse to approve a drug without registration of trials.
I would like to defer to legal counsel for a more fulsome answer on that, please.